
Profitability, historical returns, and peer comparisons.
According to Quest Diagnostics Incorporated’s latest financial reports and current stock price. The company's current ROE is 15.21%. This represents a change of 300.79% compared to the average of 3.80% of the last 4 quarters.
The mean historical ROE of Quest Diagnostics Incorporated over the last ten years is 16.74%. The current 15.21% ROE has changed -9.09% with respect to the historical average. Over the past ten years (40 quarters), DGX's ROE was at its highest in in the June 2021 quarter at 10.65%. The ROE was at its lowest in in the December 2022 quarter at 1.71%.
Average
16.74%
Median
14.66%
Minimum
12.85%
Maximum
30.96%
Discovering the peaks and valleys of Quest Diagnostics Incorporated ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 46.23%
Maximum Annual ROE = 30.96%
Minimum Annual Increase = -48.15%
Minimum Annual ROE = 12.85%
| Year | ROE | Change |
|---|---|---|
| 2025 | 13.84% | 7.67% |
| 2024 | 12.85% | -5.10% |
| 2023 | 13.54% | -15.65% |
| 2022 | 16.05% | -48.15% |
| 2021 | 30.96% | 46.23% |
| 2020 | 21.17% | 39.20% |
| 2019 | 15.21% | 7.79% |
| 2018 | 14.11% | -10.06% |
| 2017 | 15.69% | 12.56% |
| 2016 | 13.94% | -7.93% |
The current ROE of Quest Diagnostics Incorporated (DGX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
13.41%
5-year avg
17.45%
10-year avg
16.74%
Quest Diagnostics Incorporated’s ROE is less than Labcorp Holdings Inc. (11.54%), less than Sonic Healthcare Limited (7.20%), greater than RadNet, Inc. (-1.95%), greater than Natera, Inc. (-11.73%), less than Revvity, Inc. (3.50%), less than Illumina, Inc. (31.45%), less than Guardant Health, Inc. (211.46%), greater than GRAIL Inc. (-15.88%), less than bioMérieux S.A. (11.01%), less than Qiagen N.V. (11.60%),
| Company | ROE | Market cap |
|---|---|---|
| 11.54% | $29.83B | |
| 7.20% | $6.73B | |
| -1.95% | $6.32B | |
| -11.73% | $56.36B | |
| 3.50% | $17.79B | |
| 31.45% | $34.21B | |
| 211.46% | $22.62B | |
| -15.88% | $6.42B | |
| 11.01% | $12.58B | |
| 11.60% | $10.50B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quest Diagnostics Incorporated using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Quest Diagnostics Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Quest Diagnostics Incorporated's ROE?
How is the ROE calculated for Quest Diagnostics Incorporated (DGX)?
What is the highest ROE for Quest Diagnostics Incorporated (DGX)?
What is the 3-year average ROE for Quest Diagnostics Incorporated (DGX)?
What is the 5-year average ROE for Quest Diagnostics Incorporated (DGX)?
How does the current ROE for Quest Diagnostics Incorporated (DGX) compare to its historical average?